VivoSeq
Other

Non-Steroidal Anti-Inflammatory Drugs

0

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

Non-steroidal Anti-inflammatory Drugs is an early-stage landscape with 0 programs across 1 company. The most active players are Novartis.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

78/100

Attrition Rate

15/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Novartis logo

Novartis

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

13

clinical trials

Completed7 · 54%
Unknown status3 · 23%
Terminated1 · 8%
Withdrawn1 · 8%
Recruiting1 · 8%

Clinical Trials

Trial Activity

13 trials

Non-steroidal Anti-inflammatory Drugs in Pleurodesis
Recruiting·—·Phase 2·NCT06731647·358 enrolled
Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine Including a 12 Weeks Extension and an Open-label 48 Weeks Extension Study
Completed·Novartis logoNovartis·Phase 3·NCT01029652·230 enrolled
Influence of Non-steroidal Anti-inflammatory Drugs (NSAID) on Muscle Regeneration
Completed·—·N/A·NCT00832663·32 enrolled
Interaction Between Antihypertensives and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Completed·UUniversity of Split·Phase 4·NCT00631514·88 enrolled
CYP4A11 and CYP4F2 Gene Variants as Makers of Cardiovascular Adverse Events of Non-steroidal Anti-inflammatory Drugs
Completed·—·Phase 4·NCT02779530·20 enrolled
Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDS) on Acclimatization to High Altitude
Completed·UUniversity of California, San Francisco·Phase 1·NCT02233582·20 enrolled
Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study.
Completed·Novartis logoNovartis·Phase 3·NCT01080131·226 enrolled
Usefulness of Topical Non-Steroidal Anti-Inflammatory Drugs or Steroids Before Trabeculectomy and Clinical Outcomes
Completed·UUniversitaire Ziekenhuizen KU Leuven·Phase 3·NCT00707421·62 enrolled
Variability in Response to Non-steroidal Anti-inflammatory Drugs
Terminated·UUniversity of Pennsylvania·Phase 1·NCT02502006·16 enrolled
Total Antioxidant Effects of Esomeprazole in Dyspeptic Patients Receiving Non-steroidal Anti-inflammatory Drugs
Withdrawn·MMedstar Health Research Institute·Phase 4·NCT00443963
Comparison of Pain Sensation During Single Use of Two Topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Unknown status·SSanta Casa de Misericordia de Santos·Phase 4·NCT00869219·40 enrolled
Steroids and/ or Non-steroidal Anti-inflammatory Drugs in the Postoperative Regime After Trabeculectomy.
Unknown status·—·Phase 4·NCT04054830·70 enrolled
The Effect of Rebamipide for Non-steroidal Anti-inflammatory Drugs (NSAID) - Induced Small-intestinal Injuries
Unknown status·NNagoya University·N/A·NCT00862628·60 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)